Skip to main content

Longevity Zone

The first open innovation consultancy specializing in longevity and healthy aging.

Our Services

We offer innovative solutions that provide expertise in the development of projects related to longevity and healthy aging.


We collaborate with leading scientific institutions to generate and disseminate new knowledge on healthy longevity.


We design, conduct and deliver training and development programs on Longevity and Healthy Aging tailored to the needs of our clients with a clear focus on applicability and impact, in collaboration with other expert entities.

Scientific Consultancy

We contribute our knowledge to R&D&I departments by facilitating access to key information on longevity.

Business consulting

We provide technical, legal and commercial support to established companies or startups, to help them with our expertise in all their phases.

Medical consultancy

We advise medical centers on advances, protocols and best practices in comprehensive care related to longevity and healthy aging.

Consulting for companies and on healthy longevity in the work environment

We design and execute programs focused on supporting workplace wellness policies that facilitate optimal physical and intellectual performance throughout the years, through the integration of the pillars of wellness that facilitate healthy longevity in all its dimensions.






Vision & Mision

Longevity Zone is the result of an innovative team with an extensive and recognized track record in the field of healthy aging.

Longevity Zone's mission is to contribute to the health of the population by making scientific services specialized in longevity and healthy aging available to private companies and public organizations.

It has developed consulting projects for third parties, as well as others of its own initiative.

Meet The Team

A team to research, innovate and communicate the world of longevity and healthy aging.

“Most children born after the year 2000 in developed countries will reach 100 years of age in the 22nd century." "I know it's hard to believe, but there is no limit to human life expectancy.”

James Vaupel (1945-2022)Founding director of the Max Planck Institute for Demographic Research in Rostock (Germany)His findings, which have often sparked debate, have changed perceptions about the demography of aging.He has contributed to this statistics-linked field through a multidisciplinary approach that incorporates human and non-human biology, mathematics, genetics and public policy.
CEO. Biochemistry.

Carolina Hernández Peratta

Carolina is one of the pioneering women in the academic field of Longevity Medicine and Healthy Aging in the Spanish-speaking world.

Carolina is one of the pioneering women in the academic field of Longevity Medicine and Healthy Aging in Spanish-speaking countries.
She has created the first online Master in Spanish for doctors in Anti-Aging and Longevity Medicine at the University of Barcelona-Il3, which she also directs and has been in charge of for 18 editions in which she has trained more than 600 doctors from all over the world.

Her career includes collaborations in consulting and R&D for companies and organizations such as Haus Healthy Building, Generalitat de Catalunya, Centro Médico Teknon, Hospital Clínico de Barcelona, Kenzen, SkinGenomic, Orkla Cederroth, Candela Medical, Aloft, Eugenomic, Salangei, Tokuyama, Toskani, BEPS Holding, Grupo Sabater Análisis, Instituto Roger de Lluria, Clínica Suizo Argentina, Oncolab and Sanatorio Agote, among others.

She is Academic Director of the European Society of Calorimetry and Respirometry and Longevity Zone: Translational Longevity Medicine and Wellbeing.

She has a degree in Biochemistry from the National University of Córdoba, Argentina, is specialized in Anti-aging Medicine by WOSAAM, of which she is a member, and holds a Master's degree in Commercial Management from the University of Barcelona.

Expert in Therapeutics and Medical Innovation. Doctor of Medicine.

Joan Bigorra

Joan is recognized as one of the most innovative figures in medicine in Spain.

He has an extensive track record as PI of Medical Innovation projects and is the author of numerous articles and book chapters on the subject.

Director of Innovation at the Barcelona Institute for Global Health and Senior Innovation Advisor at the Hospital Clinic of Barcelona.

Previous professional experience:
Director of Innovation at Hospital Clínic de Barcelona (2009-2015).

General Director of the Fundació Clínic for Biomedical Research (2006-2008).

General Manager of the Pharmaceutical Division of Novartis Spain (1996-2006).

Medical and R&D Director of Boehringer Ingelheim (1995).

Medical and R&D Director of Bayer Healthcare (1985-1994).

Senior Medical Advisor of Laboratorios Esteve (1983-1985).

He is Doctor in Medicine (UAB), Medical Specialist in Clinical Pharmacology (MIR. Hospital Clínic de Barcelona), Master in Anti-Aging and Longevity Medicine (UB), Bachelor in Law (UNED), Master in Biomedicine, Biotechnology and EU Law (UNED), Diploma in Health Economics (University of Thromso, Norway), PDD by IESE (University of Navarra) and alumnus of Harvard Business School (Novartis Management Program).

He is a member of the Scientific Advisory Board of the CIBER of Bioengineering, Biomaterials and Nanomedicine of the ISCIII.

He is part of several Evaluation Committees of innovation projects such as EIT-Health , MIT Technology Review Innovators under 35 Europe and The Collider (Mobile World Congress) among others.
Director de Innovación del Instituto de Salud Global de Barcelona y Asesor Senior de Innovación del Hospital Clínico de Barcelona.

Experiencia profesional previa:
Director de Innovación del Hospital Clínic de Barcelona (2009-2015).

Director General de la Fundación Clínic para la Investigación Biomédica (2006-2008).

Director General de la División Farmacéutica de Novartis España (1996-2006).

Director Médico y de I+D de Boehringer Ingelheim (1995).

Director Médico y de I+D de Bayer Healthcare ( 1985-1994).

Asesor Médico Senior de Laboratorios Esteve ( 1983-1985).

Es Doctor en Medicina (UAB), Médico Especialista en Farmacología Clínica (MIR. Hospital Clínic de Barcelona), Master en Medicina Antienvejecimiento y Longevidad (UB), Licenciado en Derecho (UNED), Master en Biomedicina , Biotecnología y Derecho de la UE(UNED), Diplomado en Health Economics (Universidad de Thromso, Norway), PDD por IESE (Universidad de Navarra) y ex-alumno de Harvard Business School (Programa Directivo Novartis).

Es miembro del Scientific Advisory Board del CIBER de Bioingeniería, Biomateriales y Nanomedicina del ISCIII.

Forma parte de diversos Comités de Evaluación de proyectos de innovación tales como EIT-Health , MIT Technology Review Innovators under 35 Europe y The Collider (Mobile World Congress) entre otros.

Areas of activity

Longevity Zone

The first open innovation consultancy specializing in longevity and healthy aging.

Close Menu

Longevity Zone